Toggle navigation
Home
Search
Services
Blog
Contact
About
Early Therapeutics Development with Phase 2 Emphasis-261017105
Sloan Kettering Institute
Search grants from Sloan Kettering Institute
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Microdiffraction at Beamlines X25 and X29
Transcriptional Coactivators in Liver Function
Chemical Reaction Mass Spectrometry for Breath Analysis
Clinical Genetic Studies of Familial / Hereditary Cancer
Rb as A Regulator of Prostate Tumorigenesis
Recently added grants:
Pittsburgh Innovation in Collaborative Training of Residents Alliance
Roles of TET2-dependent DNA demethylation intermediates in hematological malignancies
Examining Mortality Risk and Cause of Death among California's Newborn Screening Identified Cohort with Sickle Cell Trait
Mechanisms of Erythroid Remission in Diamond Blackfan Anemia (DBA)
Peritoneal Oxygen Delivery For The Treatment Of Acute Respiratory Distress Syndrome
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA017105-010
Application #
7191423
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2005
Total Cost
Indirect Cost
Institution
Name
Sloan Kettering Institute
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2005
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
NIH 2004
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
NIH 2003
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
NIH 2002
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
Comments
Be the first to comment on this grant